Frontier Health
Develops AI healthcare technology for the healthcare market, with product details not disclosed in the available funding context.
Overview
Frontier Health is an AI healthcare company building technology for the healthcare sector. The available round information does not specify its product category, clinical focus, or customer segment, so its market positioning is best described broadly as healthcare AI. The company raised a $16 million seed round led by Atomico in June 2026. The round description notes that Atomico moved earlier than usual, indicating investor conviction at an early stage, though specific technical differentiators were not disclosed.
Funding History
Atomico led a $16M seed. Here’s what it saw in Frontier Health that convinced it to move earlier than usual
Frequently Asked Questions
- How much funding does AI Funding track for Frontier Health?
- AI Funding tracks $16M for Frontier Health across 1 funding round in this database.
- Who are Frontier Health's investors?
- Frontier Health's investors include Firstminute Capital, Atomico, XYZ Venture Capital.
- What does Frontier Health do?
- Frontier Health is an AI healthcare company building technology for the healthcare sector. The available round information does not specify its product category, clinical focus, or customer segment, so its market positioning is best described broadly as healthcare AI. The company raised a $16 million seed round led by Atomico in June 2026. The round description notes that Atomico moved earlier than usual, indicating investor conviction at an early stage, though specific technical differentiators were not disclosed.
- Where is Frontier Health headquartered?
- Frontier Health is headquartered in San Francisco, CA.
Related Insights
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $25.9 billion raised across 94 deals, with 14 mega-rounds capturing 79.8% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.
A deep comparison of Science Corp.'s neurotech-driven brain-computer interfaces and Nscale's AI cloud infrastructure, examining how $230M and $2B in recent funding fuel fundamentally different visions of artificial intelligence.